
TELA Bio Investor Relations Material
Latest events

Q1 2025
TELA Bio
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from TELA Bio Inc
Access all reports
TELA Bio Inc. is a medical technology company focused on developing and commercializing soft tissue reconstruction solutions. The company specializes in biologic and synthetic materials used in surgeries for hernia repair and abdominal wall reconstruction. TELA Bio’s products are designed to provide improved clinical outcomes by combining the strength of synthetic materials with the regenerative properties of biologic tissues. The company serves surgeons and healthcare providers, offering solutions that aim to enhance patient recovery and reduce complications. The company is headquartered in Malvern, Pennsylvania, and its shares are listed on the NASDAQ.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
TELA
Country
🇺🇸 United States